Chemoinformaics analysis of 2-METHYLTETRADEC-1-ENE
| Molecular Weight | 210.405 | nRot | 11 |
| Heavy Atom Molecular Weight | 180.165 | nRig | 20 |
| Exact Molecular Weight | 210.235 | nRing | 0 |
| Solubility: LogS | -6.519 | nHRing | 0 |
| Solubility: LogP | 7.464 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 45.0538 |
| nHD | 0 | BPOL | 30.0962 |
| QED | 0.436 |
| Synth | 4.501 |
| Natural Product Likeliness | 2.718 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.543 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.795 |
| MDCK | 0.00000709 |
| BBB | 0.739 |
| PPB | 0.978538 |
| VDSS | 2.349 |
| FU | 0.0161497 |
| CYP1A2-inh | 0.043 |
| CYP1A2-sub | 0.53 |
| CYP2c19-inh | 0.086 |
| CYP2c19-sub | 0.964 |
| CYP2c9-inh | 0.085 |
| CYP2c9-sub | 0.74 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.471 |
| CYP3a4-inh | 0.217 |
| CYP3a4-sub | 0.77 |
| CL | 9.298 |
| T12 | 0.01 |
| hERG | 0.062 |
| Ames | 0.033 |
| ROA | 0.38 |
| SkinSen | 0.032 |
| Carcinogencity | 0.024 |
| EI | 0.008 |
| Respiratory | 0.599 |
| NR-Aromatase | 0.068 |
| Antiviral | Yes |
| Prediction | 0.775177 |